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Abstract
Background: The Lysosome associated protein transmembrane (LAPTM) family is comprised of three members: LAPTM5,
LAPTM4a and LAPTM4b, with the latter previously shown to be overexpressed in numerous cancers. While we had
demonstrated earlier the requirement of the E3 ubiquitin ligase Nedd4 for LAPTM5 sorting to lysosomes, the regulation of
sorting of LAPTM4 proteins is less clear.
Methodology/Principal Findings: Here we show that LAPTM4a and LAPTM4b are localized to the lysosome, but unique to
LAPTM4b, a fraction of it is present at the plasma membrane and its overexpression induces the formation of actin-based
membrane protrusions. We demonstrate that LAPTM4s, like LAPTM5, are able to co-immunoprecipitate with the E3
ubiquitin ligase Nedd4, an interaction that is dependent on LAPTM4 PY motifs and plays a role in membrane sorting.
Accordingly, in Nedd4 knockout mouse embryonic fibroblasts (MEFs), LAPTM4a and LAPTM4b show reduced lysosomal
localization. Moreover, lack of PY motifs leads to enhanced missorting of LAPTM4b to the plasma membrane instead of the
lysosome.
Conclusions/Significance: These results suggest that while some requisites of LAPTM5 lysosomal sorting are conserved
among LAPTM4 proteins, LAPTM4a and LAPTM4b have also developed distinct sorting requirements.
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Introduction
The Lysosome Associated Protein Transmembrane (LAPTM)
family of proteins include LAPTM4a, LAPTM4b (with two major
isoforms: 35 kDa and 24 kDa [1]) and LAPTM5. LAPTM4a and
b are closely related with ,43% amino acid sequence conserva-
tion, and more distantly related to LAPTM5 (,23–25%
conservation). Sequence homology is strong in the putative a-
helical transmembrane segments and C-termini and suggests
conserved function and/or sorting of these proteins [2,3].
LAPTM4a and LAPTM4b are ubiquitously expressed, while
LAPTM5 is expressed in immune cells [1,3,4,5,6,7]. LAPTM5 has
been implicated in regulation of B cell and T cell receptor surface
expression, and is downregulated in multiple myeloma [8,9,10].
Interestingly, both LAPTM4 proteins play a role in multidrug
resistance. When overexpressed in yeast, LAPTM4a confers
multidrug resistance as a small molecule transporter capable of
altering yeast sensitivity to small molecules, such as nucleosides
and nucleobase analogs, antibiotics, anthracyclines, ionophores
and steroid hormones [7]. LAPTM4b may mediate multidrug
resistance by interacting with the multidrug resistance protein
MDR1 [11,12]. Moreover, LAPTM4b is overexpressed in various
cancers [1,3,12,13,14,15,16,17,18,19,20,21,22] and has been
implicated in the tumorigenic process [11,21,23,24,25,26].
Overexpression of LAPTM4s may, therefore, enhance the
proliferative and/or detoxification potential of cells, likely
supporting their cancerous transformation or maintenance. Thus,
identifying LAPTM4s sub-cellular localization and the factors that
regulate their sorting could serve as the basis for strategies to
counteract deleterious consequences of their overexpression.
All LAPTM proteins are assumed to localize to the late
endosomes and lysosomes, which has been confirmed for
LAPTM5 [4,27] and LAPTM4a [5,6]. LAPTMs contain several
putative lysosomal targeting motifs in their C-termini, including
tyrosine based (YXXW), PY (L/PPXY) and dileucine ([DE]X-
XXL[LI]) motifs. With the exception of PY motifs, these motifs
are recognized by major adaptor molecules involved in trafficking
from the Golgi to the lysosome (directly or indirectly via the
plasma membrane) including the adaptor proteins AP1 to AP4
and GGA1-3 [28]. APs and GGAs bind cargo, protein coats and
other accessory proteins for transport to and from specific
compartments [29,30]. Our lab recently demonstrated that
lysosomal targeting of LAPTM5 is dependent on its C-terminal
PY motifs, ubiquitin interacting motif (UIM) and an interaction
with the E3 ubiquitin ligase Nedd4 (neuronal precursor-cell
expressed developmentally down-regulated 4) [27]. Nedd4 pro-
teins are comprised of a C2 domain, 3–4 WW domains that bind
substrates by interacting with PY motifs, and a ubiquitin ligase
HECT domain [31]. This mode of sorting is also used by the yeast
vacuolar protein Sna3p [32]. Interestingly, both LAPTM4a and b
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investigated to date.
Here, we investigated the lysosomal and plasma membrane
sorting of LAPTM4a and LAPTM4b, and show that their PY
motifs, as well as Nedd4, participate in their subcellular sorting.
We demonstrate that LAPTM4a and b, like LAPTM5, are present
in the late endosomal and lysosomal compartments, but unlike
other LAPTM members, LAPTM4b is also expressed at the
plasma membrane, a site that is favoured upon mutation of its PY
motifs.
Results
Cellular localization of LAPTM4 Proteins
LAPTM4a and LAPTM4b are closely related family members
(Figure 1). To detect sub-cellular localization of these two proteins,
we generated mCherry-tagged (mCh) LAPTM4a and LAPTM4b
(the 24 KDa isoform) constructs and expressed them in Hek293T
cells (which endogenously express these proteins). Figure 2A,B
shows that both LAPTM4a and LAPTM4b co-localized signifi-
cantly with the late endosomal and lysosomal marker Lamp1.
Unlike LAPTM4a, however, some LAPTM4b was also detected at
the plasma membrane. In support, cell surface biotinylation
experiments revealed the presence of LAPTM4b (but not
LAPTM4a) at the cell surface (Figure 2C). These results suggest
that a fraction of LAPTM4b is present at the plasma membrane.
In order to biochemically confirm the presence of LAPTM4b in
the lysosomal compartment, lysosomes were isolated from HA-
LAPTM4b overexpressing cells using magnetic affinity chroma-
tography, employing a previously described method [47,48]. As
expected, the lysosomal fraction isolated is enriched for endoge-
nous Lamp1 relative to an equal amount of post-nuclear
supernatant (PNS) input. Similar to Lamp1, HA-LAPTM4b was
detected in the lysosomal fraction, as was LAPTM4a (Figure 2D).
Figure 1. Sequence alignment of the LAPTM family of proteins. (A) ClustalW [49] amino acid sequence alignment of the LAPTM4 family
members LAPTM4a (GenBank:AAH03158.1), 24 kDa-LAPTM4b (short) (GenBank: AAH31021.1), 35 kDa-LAPTM4b (long) (NP_060877.3) and LAPTM5
(GenBank: AAI06897.1). Putative transmembrane regions (predicted by SMART [50]) are highlighted in yellow, PY motifs are bold and underlined, and
the UIM motif of LAPTM5 highlighted in blue. (B) PY motifs in the C-terminal tails of LAPTM4a and LAPTM4b are indicated in bold. Putative Tyrosine-
based motifs are underlined. The dileucine motif is indicated in green (italicized), with the bold Leu shared with the PY motif. Tyrosine residues shared
by tyrosine-based and PY motifs are indicated in red.
doi:10.1371/journal.pone.0027478.g001
Nedd4 Regulates Sorting of LAPTM4 Proteins
PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27478Interestingly, our results show that cells expressing LAPTM4b also
exhibit hair-like membrane protrusions that largely co-stained with
the plasma membrane marker Concanavalin A (ConA), (Figure 2A,
Table 1, Figure S1). In addition, the nature of the protrusions was
examined by staining Hek293T cells either untransfected or
transfected with mCherry or mCh-LAPTM constructs with the
actin-binding protein phalloidin (Figure 3). Untransfected, mCh-,
LAPTM5 and LAPTM4a -expressing cells showed similar and
minimal hair-like protrusions (Figure 3A). In contrast, mCh-
LAPTM4b expressing cells on average had approximately twice as
many and twiceas long actin-based membrane protrusions relative to
untransfected or mCh-transfected cells (Figure 3A,B and Table 2).
Figure 2. Both LAPTM4 proteins localize to lysosomes, but LAPTM4b is uniquely present also at the cell surface. (A) 24 hrs post
transfection the plasma membrane (ConA, green) of Hek293T cells expressing mCh-LAPTM4a (red, top) or mCh-LAPTM4b (red, bottom) was stained,
cells were fixed and incubated with anti-Lamp1 antibodies (blue). White arrows indicate mCh-LAPTM4b in hair-like protrusions. Cells were imaged
using LSM510 and subcellular localization was assessed using Volocity 5.4.1. (B) Colocalization of LAPTM4s with the lysosomal marker Lamp1 was
expressed in terms of the Pearson’s correlation coefficient. Degrees of freedom are noted as (r), level of significance as (p). n=37 for LAPTM4a and
LAPTM4b. (C) Untransfected or transfected (mCh-LAPTM4a-WT or mCh-LAPTM4b-WT) Hek293T cells were subjected to cell surface biotinylation, lysis,
pulldown with streptavidin agarose beads and separation on SDS-PAGE. Cell surface biotinylation of the Transferrin receptor (TfR) was used as a
positive control. (D) Biochemical evidence for the presence of LAPTM4 proteins in lysosomes: Lysosomal fraction from Hek293T cells overexpressing
HA-LAPTM4a or b were isolated as described in the Materials and Methods section. Post nuclear supernatant (PNS) was loaded on a magnetic
column, the flowthrough (F) was collected and upon removal of the column from the magnet the lysosomal fraction (L) was eluted. Western blotting
shows significant enrichment of endogenous Lamp1 in the L fraction, as well as the presence of LAPTM4a or b.
doi:10.1371/journal.pone.0027478.g002
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LAPTM5 was previously shown to interact with the E3
ubiquitin ligase Nedd4 via its C-terminal PY motifs [27]. Since
PY motifs are also present in LAPTM4a and LAPTM4b
(Figure 1B), we investigated their ability to bind Nedd4 in cells.
Co-immunoprecipitation (co-IP) experiments were performed
using cell lysates from Hek293T cells co-expressing V5-tagged
Nedd4 and mCh-tagged LAPTM4a or LAPTM4b. Figure 4A and
B show that both LAPTM4a and LAPTM4b were able to co-IP
with Nedd4. Moreover, co-IP of LAPTM4a and LAPTM4b with
Nedd4 was dependent on the presence of their PY motifs;
Mutating all of LAPTM4a’s 3 PY motif or LAPTM4b’s 2 PY
motif prolines to alanines (mCh-LAPTM4a-3PA or mCh-
LAPTM4b-2PA) abolished binding to Nedd4 (Figure 4A, B).
LAPTM4a’s second (P213) and third (P228) PY motif appear most
important for this interaction, as they are both unable to bind
Nedd4 when mutated to Ala, while mutation of the 1
st PY motif
(P208A) reduces, but does not eliminate, the binding of LAPTM4a
to Nedd4 (Figure 4A). In addition, as with LAPTM5 [27] we show
that Nedd4 can ubiquitinate both LAPTM4 proteins (Figure S2,
Materials and Methods S1). Together, these experiments suggest
that LAPTM4a and LAPTM4b bind Nedd4 in cells, and that this
interaction is mediated via the LAPTM4a PY motifs.
The PY motifs of LAPTM4 proteins regulate their
sub-cellular distribution
Because LAPTM4s interact with Nedd4 via their PY motifs and
we previously showed that LAPTM59s PY motifs are required for
its proper localization to the lysosome in Hek293T and dendritic
cells (DC) [27], we investigated whether the LAPTM4 PY motifs
participate in their lysosomal targeting. Hek293T cells were
transfected with WT or PY motif mutant LAPTM4a and
LAPTM4b. At 24 hrs post transfection the subcellular localization
of the LAPTM4 proteins was assessed by confocal microscopy.
Figure 5 shows that while WT LAPTM4a and LAPTM4b both
co-localized with the late endosome and lysosomal marker Lamp1,
the PY motif deficient mCh-LAPTM4a-3PA shows significantly
reduced co-localization (,24% drop in colocalization). Interest-
ingly mCh-LAPTM4b-2PA colocalization with Lamp1 was largely
unchanged (,2% drop in colocalization) (Figure 5B). This suggests
that LAPTM4a and LAPTM4b differ in their dependence on the
PY motifs for lysosomal sorting, with LAPTM4a being dependent
and LAPTM4b minimally dependent on these motifs.
However, we noticed that while the mCh-LAPTM4b-2PA
mutant was still able to localize to the lysosome, its surface
expression appeared to have increased. In order to further
investigate this observation, an experiment was conducted in
which untransfected, mCh-LAPTM4a-WT, mCh-LAPTM4b-WT
or mCh-LAPTM4b-2PA expressing Hek293T cells were subjected
to cell-surface biotinylation. As seen in Figure 5C, there appears to
be more mCh-LAPTM4b-2PA at the cell surface than mCh-
LAPTM4b-WT. These data support the notion that the two PY
motifs of LAPTM4b are important to minimize its missorting to
the plasma membrane.
Nedd4 facilitates the proper sorting of LAPTM4 proteins
to the lysosome
Given that all LAPTMs were able to efficiently co-IP with Nedd4
andNedd4isrequiredforthe properlocalizationofLAPTM5tothe
lysosome [27], we investigated the role of Nedd4 in LAPTM4
lysosomal targeting using Nedd4 knockout (Nedd4
2/2) MEFs that
we recently generated [33]. WT or Nedd4
2/2 MEF cells were
transfected with mCh-LAPTM4a or mCh-LAPTM4b. After
24 hrs, the cells were fixed and stained with the lysosomal marker
(Lamp1) and co-localization of the LAPTM4 protein was assessed
using confocal microscopy (Figure 6). mCh-LAPTM4a expressed in
WT MEFs showed strong colocalization with the lysosomal marker
Lamp1 (Figure 6A). In contrast, LAPTM4a exhibited severely
reduced (by 50%) lysosomal localization when expressed in
Nedd4
2/2 MEFs (Figure 6B,C). mCh-LAPTM4b expressing WT
MEF cells showed some colocalization with the lysosomal marker
Lamp1 and plasma membrane staining (Figure 6A). Quantification
of the colocalization between mCh-LAPTM4b and Lamp1 in
Nedd4
2/2 and WT MEFs, revealed a decrease in colocalization of
only ,14%. This decrease is much smaller than that observed for
LAPTM4a (Figure 6B,C), but is nonetheless significant. These
results suggest that Nedd4 plays a significant role in the lysosomal
sorting of LAPTM4a and a lesser, but still significant, role in that of
LAPTM4b.
Discussion
Our studies here provide evidence (i) that LAPTM4b, like
LAPTM4a and LAPTM5, localizes to lysosomes, (ii) that both
LAPTM4a and LAPTM4b can co-IP with the ubiquitin ligase
Nedd4 and can be ubiquitinated by it, albeit at different strengths,
and (iii) that sorting of LAPTM4a (and to a lesser extent
LAPTM4b) is dependent on interaction with Nedd4, similar to
our previous observation with LAPTM5. However, despite these
commonalities, we also show that LAPTM targeting is not entirely
conserved: LAPTM4b, unlike other LAPTMs, also localizes to the
plasma membrane (and appears to enhance the formation of actin-
based membrane protrusions) and its dependence on Nedd4 for
lysosomal sorting is weaker than that of LAPTM4a. Moreover,
LAPTM4b sorting to the plasma membrane is enhanced upon of
loss of its PY motifs, suggesting that Nedd4 normally prevents it
from sorting to the cell surface.
Our current studies, along with our (and others’) earlier work,
indicate that all LAPTM proteins reside within the endo-lysosomal
system. While localization was previously shown for LAPTM5
[4,27] and LAPTM4a [5,6], LAPTM4b localization had been
assumed to be lysosomal from its association with membrane
Table 1. mCh-LAPTM4b co-stains with membrane-protrusions when overexpressed in Hek293T cells.
Cells in which LAPTM4b is PRESENT in
actin-based membrane protrusions
Cells in which LAPTM4b is ABSENT from
actin-based membrane protrusions
Experiment
Total Number of Cells
Observed # cells % of Total Cells # cells % of Total Cells
1 29 26 89.7 3 10.3
2 37 32 86.5 5 13.5
doi:10.1371/journal.pone.0027478.t001
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[1,18,19,21,34]. The lysosomal localization of LAPTM4 proteins
supports their putative roles in small molecule transport ([7,11,12]
and Milkereit et al. (unpublished data)), as sequestration of
bioactive compounds to this organelle precludes their activity
[6,7,12]. The detection of LAPTM4b at the plasma membrane is
in accord with the observation that it is able to bind to MDR1 (a
plasma membrane expressed multidrug transporter) [11] and
agrees with the expression pattern of other multidrug transporters
which are found simultaneously at the plasma membrane and
internal organelles (Golgi/Endosomes/Lysosomes) [35,36]. Since
LAPTM4b is the only LAPTM member present at the cell surface,
Figure 3. LAPTM4b, but not LAPTM4a or LAPTM5, is present in actin-based membrane protrusions in Hek293T cells. (A) Hek293T cells
were transfected with mCherry alone, mCh-LAPTM4b-WT, mCh-LAPTM4a-WT or mCh-LAPTM5-WT (red). 24 hrs post transfection cells were fixed and
stained with anti-Lamp1 antibody (blue) and Phalloidin (green). (B) Additional images illustrate the changes in actin-based membrane protrusions
associated with mCh-LAPTM4b-WT expression (relative to mCherry-alone expressing cells) in two independent experiments (1 and 2). All images were
taken with LSM510 and analyzed by Volocity 5.4.1 (Perkin Elmer). White arrows indicate examples of actin-based membrane protrusions in which
mCh-LAPTM4b is present.
doi:10.1371/journal.pone.0027478.g003
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include the formation of membrane protrusions. The actin-based
membrane protrusions induced by LAPTM4b are reminiscent of
filopodia associated with the epithelial-mesenchymal transition
(EMT) and metastasis of cancerous cells [37,38,39]. It is possible
that filopodia growth contributes to the increased invasive
potential and metastasis associated with LAPTM4b overexpressing
cancers and cells [21,25,26]. While the membrane protrusions we
observed were likely enhanced by LAPTM4b overexpression, such
overexpression is common in numerous cancers and likely
contributes to the metastatic potential of LAPTM4b -expressing
cells, as described above.
We have shown that LAPTM4 proteins, like LAPTM5,
coimmunoprecipitates with Nedd4. We believe that this interac-
tion is most likely direct, as this co-IP was abolished by mutating
the LAPTM4 PY motifs. While we cannot currently prove that
mutation of the PY motifs did not cause other alteration in the
LAPTM4 proteins that resulted in loss of binding to Nedd4, the
PY motif mutants appear to be expressed at the right size and
appear stable, suggesting that they are not misfolded.
Our localization studies suggest Nedd4 plays differing roles for
each LAPTM member. In the case of LAPTM5, we previously
established that the loss of Nedd4 or functional PY motifs, resulted
in LAPTM5 Golgi retention [27]. This stands in contrast with the
phenotype observed for LAPTM4s: in the absence of PY motifs or
Nedd4 LAPTM4a exits the Golgi, but co-localization with Lamp1
positive vesicles decreases (,50%). Similarly, the loss of PY motifs
in LAPTM4b, or lack of Nedd4, does not affect Golgi exit and
only partially affects lysosomal localization. Instead, the absence of
PY motifs enhances the proportion of LAPTM4b at the cell
surface. The role of Nedd4 in regulating lysosomal versus plasma
membrane sorting described here is reminiscent of nutrient-
dependent sorting of Gap1 permease in yeast, which is controlled
via Gap1 ubiquitination by Rsp5, the S. cerevisae orthologue of
Nedd4 [40,41]. In addition, while LAPTM5 possesses a UIM
motif that is also necessary for its lysosomal sorting (by interacting
with ubiquitinated GGA3) [27], LAPTM4 proteins lack UIM
motifs. In accord, our preliminary data show that unlike LAPTM5
[27], LAPTM4a cannot bind ubiquitin. Thus, despite sequence
similarities between the LAPTM family members, the regulation
of their sub-cellular localization is not identical (Figure S3).
In fact, the greater the LAPTM4 sequence differs from that of
LAPTM5, the smaller the role of Nedd4 appears to be in its
sorting. This relationship may be secondary to the number and
context of LAPTM4 PY motifs. Like LAPTM5, LAPTM4a
contains three PY motifs, whereas LAPTM4b contains only two.
While a single PY motif is sufficient to bind a WW domain, it is
possible that having numerous PY motifs could enhance binding
avidity. Furthermore, the context of the PY motifs may affect
Nedd4’s ability to mediate targeting. Based on Figure 1B, one
could speculate that other LAPTM4 C-terminal putative lyso-
somal targeting motifs, in addition or in combination with PY
motifs, could play a role in LAPTM4 lysosomal targeting. Should
additional motifs play a role, access to PY motifs could be
spatiotemporally controlled. For instance, if a tyrosine-based motif
or a dileucine motif has a higher affinity for their binding partner
than a neighboring or overlapping PY motif, the PY motifs may
become obscured. This is particularly relevant when considering
the LAPTM4b PY motifs, which share residues not only with a
potential dileucine targeting motif, but also a putative tyrosine
based motif. Indeed, two tandemly arranged tyrosine-based
(YXXW) motifs were previously proposed to be involved in
LAPTM4a lysosomal sorting[2]. However, the substitution
mutation made to the tyrosine of the 2
nd YXXW motif
simultaneously disrupted a PY motif (Figure 1B) raising the
possibility that a disrupted PY motif may have contributed (wholly
or in part) to the observed missorting. Nonetheless, involvement of
additional putative lysosomal targeting motifs may explain why
,50% and 86% of LAPTM4a and LAPTM4b, respectively, were
correctly sorted to lysosomes, despite the absence of Nedd4 in our
MEFs. Having numerous lysosomal targeting motifs may mediate
efficient lysosomal delivery even if one or more lysosomal targeting
pathways are impaired [42,43]. Such a mechanism for LAPTMs
remains speculative, but would be relevant considering the
potential consequences of LAPTM4 mislocalization with respect
to small molecule transport [7,11,12] and/or cell signalling
[11,21,23,24,26].
Additionally, while ubiquitination of LAPTM4b occurs in the
presence ectopically expressed Nedd4, and is reduced in the presence
of a catalytically inactive Nedd4(CS)(Figure S2, Materials and Methods
S1), LAPTM4b is also ubiquitinated in Hek293Ts that are not
transfected with Nedd4. This suggests that either endogenous Nedd4
(expressed in these cells) or/and other E3 ligases, is/are responsible for
this ubiquitination. Potential other E3s may include additional Nedd4
family members, which also possess WW domains capable of binding
PY motifs [31]. If other Nedd4 family members bind to and/or
ubiquitinate LAPTM4b, this could also contribute to the different
localization patterns observed when WT LAPTM4b is expressed in
Nedd4
2/2 MEFs (Figure 6A) and LAPTM4b-2PA in Hek293Ts
(Figure 5A). While the absence of PY motifs results in an accumulation
of LAPTM4b at the cell surface without altering lysosomal localization,
the absence of Nedd4 leads to a minor decrease in LAPTM4b
Table 2. Hek293T cells in which mCh-LAPTM4b is overexpressed have longer and higher density of actin-based membrane
protrusions.
Hek293T
Protrusions Property Experiment Untransfected (n=20) mCh(n=20) mCh-LAPTM4b (n=20) Statistical Significance
c
Average length (mm)
a 1 1.96360.104 2.26760.189 3.50560.092 p,0.0001
2 1.54560.086 1.77560.122 3.38360.165 p,0.0001
Average density
(# protrusions/ mm
2)
b
1 0.02760.003 0.02460.003 0.056060.004 p,0.0001
2 0.03460.003 0.02060.002 0.064860.008 p=0.0024
a,bThe average protrusion length/density is indicated 6 SEM.
cA student t-test was performed to determine the statistical significance of the difference between average length/density of actin protrustions of mCh-LAPTM4b and
untransfected cells.
doi:10.1371/journal.pone.0027478.t002
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such a scenario, we speculate that a LAPTM4b PY motif mutant might
be unable to bind any Nedd4 family member via their WW domains.
Other alternative motifs could then target LAPTM4b to the lysosome
and play a role in the accumulation of LAPTM4b at the plasma
membrane. In the absence of Nedd4 in the Nedd4
2/2 MEFs, other
Nedd4 family members could potentially assist in the clearance of
LAPTM4b from the plasma membrane.
In conclusion, our results show Nedd4 and PY motifs are
involved in LAPTM4 sorting. We believe that PY motifs may play
a role in the sorting of additional lysosomal proteins. Of the 215
integral membrane proteins identified in rat liver tritosomes
(lysosomes) [44], we identified 20 that possess PY motifs in humans
(Table S1, Materials and Methods S1). Whether any of these is/
are also regulated by Nedd4 family members remains to be
established.
Materials and Methods
Cell Lines, Antibodies and Reagents
Hek293T cells (Obtained from ATCC) were cultured in
DMEM supplemented with 10% fetal bovine serum (FBS),
100 U/ml penicillin, and 100 mg/ml streptomycin. Cells were
transfected using the calcium phosphate transfection method[45].
Figure 4. LAPTM4a and LAPTM4b bind Nedd4 via their PY motifs. (A) LAPTM4a’s binding to Nedd4 is dependent on its 2nd and 3rd PY
motifs. A Co-IP was performed on whole cell lysates from Hek293T cells co-expressing V5-tagged Nedd4 and mCh-LAPTM4a (WT, 3PA, P208A, P213A
or P228A). Nedd4 was precipitated using anti-V5 antibodies, samples were separated on SDS-PAGE and transferred to nitrocellulose. Anti-mCherry
antibodies were used to detect binding of mCh-LAPTM4s to Nedd4. (B) LAPTM4b binding to Nedd4 is dependent on its PY motifs. A CoIP was
performed on whole cell lysates from Hek293T cells co-expressing V5-tagged Nedd4 and mCh-LAPTM4a-WT, mCh-LAPTM4b-WT or mCh-LAPTM4b-
2PA, as in (A).The housekeeping proteins Tubulin and GAPDH were used interchangeably as loading controls for the cell lysates. (IgG bands are
detected due to the HRP-conjugated 2
o antibody’s specificity for mouse Ig, which detects the Ig heavy and light chains of the V5 antibody used
during the pulldown.).
doi:10.1371/journal.pone.0027478.g004
Nedd4 Regulates Sorting of LAPTM4 Proteins
PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27478Nedd4 Regulates Sorting of LAPTM4 Proteins
PLoS ONE | www.plosone.org 8 November 2011 | Volume 6 | Issue 11 | e27478Mouse embryonic fibroblasts (MEF) (WT and Nedd4
2/2 MEF)
were generated as described earlier[33]. MEF cells were cultured
in DMEM supplemented with 10% FBS, 100 U/ml penicillin,
100 mg/ml streptomycin and 100 mg/ml glutamine. They were
transfected according to the manufacturer’s protocol using
ESCRTV transfection reagent (Sigma-Aldrich). For confocal
imaging: Mouse monoclonal [H4A3] to Lamp1 (Abcam), rat
anti-mouse Lamp1 (BD Pharmingen), Normal Goat Serum
(Jackson ImmunoResearch Laboratories Inc.), Alexa-Fluor 647
conjugated ConcanavillinA (ConA, Invitrogen), Alexa-Fluor 488
Conjugated Phalloidin (Invitrogen), Alexa-Fluor 488 Goat-anti
mouse 2
o antibody (Invitrogen), Alexa-Fluor 488 Goat-anti rat 2
o
antibody (Invitrogen). Slides were mounted using Darkocytoma-
tion (Dako Corporation). For Immunoprecipitation and Western
Blotting: Peroxidase-conjugated AffiniPure Goat Anti-Mouse
IgG(H+L) (Jackson ImmunoResearch laboratories Inc.), Living
Colors mCherry Monoclonal Antibody (Clontech), GAPDH (A-3,
Santa Cruz), anti-Human Transferrin receptor antibody #13-
6800 (Zymed), anti-Tubulin (Sigma), anti-b-actin (Sigma), anti-
Hemagglutinin (HA, Covance), anti-V5 (AbDserotec), anti-Penta-
His (Invitrogen), anti-Lamp1 (Abcam). Protein-G Agarose (Bio-
Shop Canada), Streptavidin Agarose (Thermo Scientific). Nickel-
NTA Agarose Beads (Qiagen). LLnL (N-acetyl-Leu-Leu-norleuc-
inal, Sigma).For Biotinylation: EZ-link Sulfo-NHS-SS-biotin
(Thermo Scientific). Developed with Western Lightning
TMPlus-
enhanced chemiluminescence (ECL,Perkin Elmer). miniMACS
columns for magnetic affinity chromatography (Miltenyi Biotec
Inc.).
Constructs
We obtained cDNA entry clones of human LAPTM4a
(GenBank: AAH03158.1) and LAPTM4b (the 24 kDa isoform,
GenBank: AAH31021.1) from Invitrogen, and used these cDNAs
in all our experiments. Site directed mutagenesis was used to
mutate the 2
nd conserved Proline in the PY-motifs (L/PPXY) to
Alanine. LAPTM4a single PY-motif mutants are P208A, P213A,
P228A, while the total PY motif mutant is LAPTM4a-3PA. The
total PY motif mutant of LAPTM4b is LAPTM4b-2PA (mutated
residues are P205A and P221A). WT and PY motif mutants were
N-terminally tagged with mCherry or HA (Hemagglutinin) using
the Gateway cloning system (Invitrogen). The histidine-tagged
ubiquitin construct (His-Ub) was provided by D. Bohmann
(University of Rochester Medical Center, Rochester, NY;[46]).
Immunofluorescent Confocal Microscopy
Hek293T and MEF cells were cultured on poly-D-Lysine
coated coverslips in 6-well-plates. 24 hrs post transfection wells
were washed 3x with 1 ml PBS and incubated 5 min with Alexa-
Fluor-647-conjugated ConA (1:1000). After three PBS washes,
cells were fixed with 4% Paraformaldehyde (PFA), permeabilized
with 0.1% Triton X-100 and incubated with 1:100 Normal Goat
Serum in 3% Skim Milk (30 min). Slides were incubated 1 hr with
mouse anti-human (Hek293T) or rat anti-mouse (MEFs) Lamp1
(1:1000) in 3% Skim milk. After three PBS washes, cells were
incubated with Goat anti-mouse or anti-rat Alexa 488 Fluor-
conjugated antibody. When applicable, Phalloidin-staining
(1:1000) was performed concurrently with the 2
0 antibody. Cover
slips were mounted with Dako Cytomation and imaged with a
LSM510 confocal microscope at 63x magnification with a 1.4NA
oil-immersion objective (Carl Zeiss MicoImaging, Inc.). Coloca-
lization of Lamp1 and mCh-tagged LAPTM4s was assessed by
Volocity 5.4.1 (Perkin Elmer) and expressed in terms of the
Pearson’s correlation coefficients.
Characterization of the Actin-based Membrane
Protrusions
Hek293T cells (untransfected, or transfected with mCh- or
mCh-LAPTM4b-WT) were stained with phalloidin as described
above. The length of actin-based membrane protrusions was
determined using the line tool in Volocity 5.4.1 (Perkin Elmer).
Each phalloidin-stained actin-based membrane protrusion was
measured per cell and the average length of the protrusions was
determined. The average density of protrusions per mm
2 was
determined by computing the total number of actin-based
membrane protrusions per cell divided by the total cell’s surface
area. The average length and density of the protrusions indicated
per condition (untransfected, mCh- or mCh-LAPTM4b-WT) in
Table 2 represent the average length and density of actin-based
membrane protrusions of 20 cells.
Co-Immunoprecipitation (Co-IP) Assays
Hek293T cells were co-transfected with mCh-tagged LAPTM4s
and V5-tagged Nedd4. 24 hrs post transfection media was changed.
At 48 hrs, cells were lysed on ice in 1 ml Lysis buffer (50 mM
Hepes, pH 7.5, 150 mN NaCl, 1% Triton X-100, 10% glycerol,
1.5 mM MgCl2, 1.0 mM EGTA, 10 mg/ml leupeptin, 10 mg /ml
aprotinin, 10 mg /ml pepstatin, 1 mM PMSF) and centrifuged at
20817rcf(g) (30 min, 4uC).1 mgoflysatewas incubatedwith 1.5 ml
anti-V5antibodyand 15 mlProtein-GSepharosebeads(4uC,4 hrs).
Tubes were spun at 425 rcf (g) (3 min), washed 3x with Lysis Buffer
and 3x with low salt HNTG (20 mM Hepes, pH 7.5, 150 mM
NaCl, 10% glycerol, and 0.1% TritonX-100). Proteins were eluted
with 30 ml 1xSDS-PAGE sample buffer, resolved on 15% SDS-
Poly-acrylamide Gels (SDS-PAGE) and transferred to nitrocellu-
lose. Upon cell lysis, 50 mg of fresh cell lysate are set aside and
loaded on the same 15% SDS-PAGE gel as ‘‘Lysate.’’ This serves as
a control to confirm and monitor the expression of the transfected
proteins. For Western blotting: the membrane was blocked in 3%
Dry Milk (30 min), incubated 1 hr with primary antibody (anti-
mCh 1:2500; anti-V5 1:5000; anti-GAPDH 1:1000, anti-Tubulin
1:1000), washed 3x with wash buffer (PBS, 0.1% Triton X-100),
incubated with Horseradish peroxidase conjugated Goat anti-
mouse IgG (45 min) and developed using enhanced chemilumines-
Figure 5. LAPTM4a and LAPTM4b require their PY motifs for proper targeting. (A) 24 hrs post transfection the plasma membrane of
Hek293T cells expressing mCh-LAPTM4a-WT, mCh-LAPTM4a-3PA, mCh-LAPTM4b-WT or mCh-LAPTM4b-2PA was stained (ConA, blue), cells were
fixed, incubated with anti-Lamp1 antibodies (green) and imaged by confocal microscopy. Subcellular localization of LAPTM4 was assessed using
Volocity 5.4.1. (B) LAPTM4 colocalization with the lysosomal marker Lamp1 is expressed in terms of the Pearson’s correlation coefficient. Degrees of
freedom are noted as (r), level of significance as (p). Graphs illustrate changes in the mean Pearson’s coefficients of mCh-LAPTM4 colocalization with
Lamp1 (LAPTM4a n=32, LAPTM4b n=82). Error bars indicate SEM. * denotes p,0.0001. (C) Cell surface expression of mCh-LAPTM4b-2PA is up-
regulated relative to that of mCh-LAPTM4b-WT. Cell surface biotinylation was performed on Hek293T cells expressing mCh-LAPTM4a-WT, mCh-
LAPTM4b-WT or mCh-LAPTM4b-2PA. Cell surface biotinylation of Transferrin receptor (TfR) served as a positive control, while cell surface biotinylation
of mCh-LAPTM4a-WT and GAPDH served as negative controls.
doi:10.1371/journal.pone.0027478.g005
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2/2 MEF cells were transfected with (wildtype)
mCh-LAPTM4a or mCh-LAPTM4b (red). 24 hrs post transfection the plasma membranes was stained (ConA, blue), cells were fixed and incubated with
anti-Lamp1 antibodies (green). Cells were imaged by confocal microscopy and subcellular localization was assessed using Volocity 5.4.1. (B) LAPTM4
colocalization with the lysosomal marker Lamp1 is expressed in terms of the Pearson’s correlation coefficient. Degrees of freedom are noted as (r),
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Eppendorf Centrifuge 5417R.
Cell Surface Biotinylation Assay
Hek293T were transfected with mCh-LAPTM4a-WT, mCh-
LAPTM4b-WT or mCh-LAPTM4b-2PA. At 24 hrs post-trans-
fection cells were washed 3x with PBS and incubated with 3 ml of
1 mg/ml EZ-link Sulfo-NHS-SS-biotin in PBS (1 hr, 4uC). Cells
were washed 3x in PBS and lysed in 1 mL Lysis Buffer. Lysates
were collected and centrifuged at 20817 rcf(g) (30 min, 4uC).
Upon cell lysis, 50 mg of fresh cell lysate are set aside and loaded
on the same SDS-PAGE gel as ‘‘Lysate.’’ This serves as a control
to confirm and monitor the expression of the transfected proteins.
1 mg of supernatant was incubated with 30 ml Streptavidin
agarose beads (4 hrs, 4uC). Beads were spun at 956 rcf (g)
(2 min), washed 3x with 1 ml Lysis Buffer and 3x 1 ml Low Salt
HNTG. Biotinylated proteins were eluted in 30 mL 1xSDS-PAGE
sample buffer (5 min, 100uC). Samples were resolved by 15%
SDS-PAGE and transferred to nitrocellulose. Western blotting:
membrane was blocked in 3% Dry Milk (30 minutes), incubated
with anti-mCherry (1:2500); anti-Transferrin (1:1000) or anti-
GAPDH (1:1000) for 1 hr. Blots were washed 3x with wash buffer,
incubated with Horseradish peroxidase conjugated Goat anti-
mouse IgG (45 min) and were developed with ECL.
Isolation of Lysosomes using Magnetic Affinity
Chromatography
Lysosomes were isolated as previously described by magnetic
affinity chromatography using superparamagnetic (Iron-Dextran
(FeDex)) particles [47,48]. Briefly, Hek293T in 20 cm dishes were
transfected with 20 mg HA-LAPTM4a or b. At 24 hrs the cells
were incubated with 20 ml colloidal iron dextran particles in
20 ml lyophilized media. After 9 hrs, cells were washed 3x with
PBS and chased with fresh media overnight. Cells were washed 1x
with PBS, trypsinized, collected in 5 mL fresh media and spun at
956 rcf (g) for 5 min. Lysosomes were isolated at 4uC. The pellet
was resuspended in 40 ml homogenization buffer (0.25 M sucrose,
4 mM imidazole, pH 7.4, 10 mg/ml leupeptin, 10 mg/ml aproti-
nin, 10 mg/ml pepstatin, 1 mM PMSF) and spun at 956 rcf (g) for
5 minutes. The pellet was homogenized in 2 ml homogenization
buffer and spun for 10 min. at 956 rcf (g). 1 ml post-nuclear
supernatant (PNS) was collected and loaded onto a miniMACs
column on a magnet. The flowthrough (F) was collected and the
column was washed 2x with homogenization buffer. The column
was removed from the magnet and the lysosomal fraction was
eluted with 300 ml Elution Buffer (5 mM Tris pH 7.4, 150 mM
NaCl, 0.1% Triton). 10 mg of untransfected Hek293T cell lystate,
PNS, Flowthrough (F), and Lysosomal Fraction (L) were loaded on
a 15% SDS-PAGE and transferred to nitrocellulose. A western
blot was performed as described for Co-IP experiments, with anti-
Lamp1 (1:1000) or (1:10 000) anti-HA antibodies.
Supporting Information
Figure S1 mCh-LAPTM4b co-stains with plasma mem-
brane protrusions. Three view fields selected at random of
Hek293T cells (Table 1) expressing mCh-LAPTM4b (red) at
24 hrs post transfection are shown. The plasma membrane is
stained with ConA (green). Cells were imaged using LSM510. The
brightness of the red channel has been increased approximately 2
fold using Volocity 5.4.1.
(TIF)
Figure S2 Nedd4 ubiquitinates LAPTM4a and
LAPTM4b in cells. (A) LAPTM4a is ubiquitinated by Nedd4.
Hek293T cells co-expressing V5-tagged Nedd4 (WT or catalyti-
cally inactive CS mutant) and HA-LAPTM4a (WT or 3PA) and
His-Ub were lysed, lysate boiled in SDS to dissociate putative
interacting proteins, and diluted (see Methods). Proteins tagged by
His-Ub were precipitated using Ni-NTA agarose beads, samples
were separated on SDS-PAGE and transferred to nitrocellulose.
Anti-HA antibodies were used to detect His-Ubiquination of
LAPTM4a. (B) LAPTM4b is ubiquitinated by Nedd4. As in (A),
except using WT or 2PA HA-LAPTM4b. Actin is used as a
housekeeping protein for the lysate loading control.
(TIF)
Figure S3 Schematic representation of the contribution
of Nedd4 to lysosomal sorting of LAPTM proteins (tested
in Hek293T cells), depicting varying dependency on
Nedd4, with LAPTM5 being highly-dependent (and also
collaborating with GGA3), LAPTM4a exhibiting inter-
mediate dependency (,50%), and LAPTM4b minimally
dependent on Nedd4. ? represents other (unknown) factors.
(TIF)
Table S1 Examination of the 215 peptide sequences of
proteins identified as resident lysosomal integral mem-
brane proteins in a screen of rat liver tritosomes[44],
has identified 20 proteins with conserved PY motifs in
rat and human proteins using DNAassist (v3.0, Univer-
sity of the Free State).
(DOC)
Materials and Methods S1 Ubiquitination Assay. Identi-
fication of PY Motif containing lysosomal proteins.
(DOC)
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